-
Mashup Score: 0Vaxarts COVID19 Vaccine Shows Promise Against Variants and Receives Funding Boost from BARDA - 10 month(s) ago
Vaxart, Inc. has recently shared groundbreaking findings in the journal Vaccines, highlighting the remarkable potential of their COVID-19 vaccine to
Source: beststocks.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 0
Neurosense Therapeutics Ltd, a pioneering company in the field of neurodegenerative disease treatment, is revolutionizing the way we approach conditions
Source: beststocks.comCategories: Latest Headlines, Rare DiseaseTweet-
Neurosense Therapeutics https://t.co/iRF9evnT7v
-
-
Mashup Score: 17
The European Medicines Agency (EMA) has made a significant announcement regarding the potential side effects of medicines containing omega-3-acid ethyl
Source: beststocks.comCategories: Expert Picks, Latest HeadlinesTweet-
EMA Announces Atrial Fibrillation as a Side Effect of Omega3 Medicines https://t.co/8tVOzTEtgO
-
“the potential of their [oral] vaccine platform to stimulate potent mucosal cross-reactive IgA responses against various variants of concern” https://t.co/WwHbJioAH9